{"id":775771,"date":"2023-08-07T06:34:19","date_gmt":"2023-08-07T10:34:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/"},"modified":"2023-08-07T06:34:19","modified_gmt":"2023-08-07T10:34:19","slug":"centogene-to-participate-in-upcoming-conferences-in-august","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/","title":{"rendered":"CENTOGENE to Participate in Upcoming Conferences in August"},"content":{"rendered":"<div class=\"mw_release\">\n<p>CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Aug.  07, 2023  (GLOBE NEWSWIRE) &#8212; Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its conference schedule for August 2023. CENTOGENE representatives are attending events in Brazil and Switzerland, and will be available to discuss Pharma, CRO, and Diagnostic collaboration opportunities. The Company invites attendees to schedule one-on-one meetings in advance.<\/p>\n<p>Please see additional details below:<\/p>\n<p>\n        <strong>XXXIV Brazilian Congress of Medical Genetics<br \/><\/strong><br \/>\n        <strong>Dates:\u00a0<\/strong>August 13-16<br \/><strong>Location:\u00a0<\/strong>Frei Caneca Convention Center, S\u00e3o Paulo, Brazil<br \/>For information about the XXXIV Brazilian Congress of Medical Genetics and to arrange a one-on-one meeting, please refer to the event webpage (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1dOvfdmff_W2c3vVnj_2HyKm5rN7eSXR3OJnuPUwNS4pO90Y9ngYO-VdCGORvj-KhRC1ywPfWOfve2I53OYFPIxm6op-7hYFGIn0KEK_f6doYoEiAzf08ED6OFiH7m93\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/link.centogene.com\/47oVr9i<\/a>).<\/p>\n<p align=\"left\">\n        <strong>BioValley Basel \u2013 Annual Event<br \/>Date:\u00a0<\/strong>August 29, 2023, 5:00 p.m. CEST<br \/><strong>Location:\u00a0<\/strong>Claraspital Auditorium, Basel, Switzerland<br \/><strong>Roundtable:\u00a0<br \/>Title:\u00a0<\/strong>Rare Diseases and Orphan Drugs \u2013 A Fascinating Pharma Subset<br \/><strong>CENTOGENE Representative:<\/strong> Kim Stratton, CENTOGENE Chief Executive Officer<br \/>Find out more about the BioValley Basel \u2013 Annual Event via the event webpage (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1dOvfdmff_W2c3vVnj_2HyKm5rN7eSXR3OJnuPUwNS7HjTBZ5ZxqD9chY1UqyxM4lxDmqM-G4AE-eBIy2hPsNw63BeqWzHeeW7mzUdrSYCpFYCUbKZlBceLP-liJ9uQh\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/link.centogene.com\/3Kut0x5<\/a>).<strong><br \/><\/strong><\/p>\n<p>\n        <strong>About CENTOGENE<\/strong><br \/>\n        \n      <\/p>\n<p>CENTOGENE\u2019s mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank \u2013 providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization.<\/p>\n<p>Since our founding in 2006, CENTOGENE has been offering rapid and reliable diagnosis \u2013 building a network of approximately 30,000 active physicians. Our ISO, CAP, and CLIA certified multiomic reference laboratories in Germany utilize Phenomic, Genomic, Transcriptomic, Epigenomic, Proteomic, and Metabolomic datasets. This data is captured in our CENTOGENE Biodatabank, with over 750,000 patients represented from over 120 highly diverse countries, over 70% of whom are of non-European descent. To date, the CENTOGENE Biodatabank has contributed to generating novel insights for more than 275 peer- reviewed publications.<\/p>\n<p>By translating our data and expertise into tangible insights, we have supported over 50 collaborations with pharma partners. Together, we accelerate and de-risk drug discovery, development, and commercialization in target and drug screening, clinical development, market access and expansion, as well as offering CENTOGENE Biodata Licenses and Insight Reports to enable a world healed of all rare and neurodegenerative diseases.<\/p>\n<p>To discover more about our products, pipeline, and patient-driven purpose, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K1H-R9zJeqR4MVV3hrxceUpxmO9VcxYYt8PKPA_OFQLPP9SE3gzgI8uuO5Vnhvj0u8W3F7CgXjwaXrfc3iBOBcWiBzdu27r_fCv8HpXqpXI=\" rel=\"nofollow noopener\" target=\"_blank\">www.centogene.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vyMVpMC63HptBKZ3j5GekvdfKy_Ly_NvsyXj7Fr--mN0de1q5XBAJw0td1lRAAM41Uodiu238ZBkR7ZItfIq7cjdhKuji0ra72ZF8XTV4HA=\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements <\/strong>\n      <\/p>\n<p>This press release contains \u201cforward-looking statements\u201d within the meaning of the U.S. federal securities laws. Statements contained herein that are not clearly historical in nature are forward-looking, and the words \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontinues,\u201d \u201cexpect,\u201d \u201cestimate,\u201d \u201cintend,\u201d \u201cproject,\u201d \u201cplan,\u201d \u201cis designed to,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cobjective\u201d and similar expressions and future or conditional verbs such as \u201cwill,\u201d \u201cwould,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201cmight,\u201d \u201ccan,\u201d and \u201cmay,\u201d or the negative of these are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause CENTOGENE\u2019s actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, negative economic and geopolitical conditions and instability and volatility in the worldwide financial markets, possible changes in current and proposed legislation, regulations and governmental policies, pressures from increasing competition and consolidation in our industry, the expense and uncertainty of regulatory approval, including from the U.S. Food and Drug Administration, our reliance on third parties and collaboration partners, including our ability to manage growth, execute our business strategy and enter into new client relationships, our dependency on the rare disease industry, our ability to manage international expansion, our reliance on key personnel, our reliance on intellectual property protection, fluctuations of our operating results due to the effect of exchange rates, our ability to streamline cash usage, our continued ongoing compliance with covenants linked to financial instruments, our requirement for additional financing and our ability to continue as a going concern, or other factors. For further information on the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to CENTOGENE\u2019s business in general, see CENTOGENE\u2019s risk factors set forth in CENTOGENE\u2019s Form 20-F filed on May 16, 2023, with the Securities and Exchange Commission (the \u201cSEC\u201d) and subsequent filings with the SEC. Any forward- looking statements contained in this press release speak only as of the date hereof, and CENTOGENE\u2019s specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise.<\/p>\n<p>\n        <strong>CONTACT<\/strong>\n      <\/p>\n<p>\n        <strong>CENTOGENE<\/strong>\n      <\/p>\n<p>Melissa Hall<br \/>Corporate Communications <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3RpaL9to3oQ6eYtcaEpzk_s8345zvO8J81QbxYM2DYqR8Dk1qPRph_sYtr9FEq-Kw0hzH__2Qz00o9K9r0RwXga8oFOWWCMn1E9CSLJ-A1Q=\" rel=\"nofollow noopener\" target=\"_blank\">Press@centogene.com<\/a><\/p>\n<p>Lennart Streibel<br \/>Investor Relations <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=95GzFwYa65JHfEo-7itSo7m2zTVP9yBlWEnVzy4tlXzCraUjdb1CrpRIMlD4cVAs766vuHg2ct6h5hvvjib-7A==\" rel=\"nofollow noopener\" target=\"_blank\">IR@centogene.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODM5NCM1NzQwMDE5IzIxMjU1NDg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YmY4NjcwNDMtMzZmYy00MzM5LTlhZjUtZTgyY2IzMTYxOWVhLTExMzcxMTk=\/tiny\/Centogene-NV.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Aug. 07, 2023 (GLOBE NEWSWIRE) &#8212; Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its conference schedule for August 2023. CENTOGENE representatives are attending events in Brazil and Switzerland, and will be available to discuss Pharma, CRO, and Diagnostic collaboration opportunities. The Company invites attendees to schedule one-on-one meetings in advance. Please see additional details below: XXXIV Brazilian Congress of Medical Genetics Dates:\u00a0August 13-16Location:\u00a0Frei Caneca Convention Center, S\u00e3o Paulo, BrazilFor information about the XXXIV Brazilian Congress of Medical Genetics and to arrange a one-on-one meeting, please refer to the event webpage (https:\/\/link.centogene.com\/47oVr9i). BioValley Basel \u2013 Annual EventDate:\u00a0August 29, 2023, 5:00 p.m. CESTLocation:\u00a0Claraspital &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CENTOGENE to Participate in Upcoming Conferences in August&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-775771","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE to Participate in Upcoming Conferences in August - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE to Participate in Upcoming Conferences in August - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Aug. 07, 2023 (GLOBE NEWSWIRE) &#8212; Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its conference schedule for August 2023. CENTOGENE representatives are attending events in Brazil and Switzerland, and will be available to discuss Pharma, CRO, and Diagnostic collaboration opportunities. The Company invites attendees to schedule one-on-one meetings in advance. Please see additional details below: XXXIV Brazilian Congress of Medical Genetics Dates:\u00a0August 13-16Location:\u00a0Frei Caneca Convention Center, S\u00e3o Paulo, BrazilFor information about the XXXIV Brazilian Congress of Medical Genetics and to arrange a one-on-one meeting, please refer to the event webpage (https:\/\/link.centogene.com\/47oVr9i). BioValley Basel \u2013 Annual EventDate:\u00a0August 29, 2023, 5:00 p.m. CESTLocation:\u00a0Claraspital &hellip; Continue reading &quot;CENTOGENE to Participate in Upcoming Conferences in August&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-07T10:34:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODM5NCM1NzQwMDE5IzIxMjU1NDg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CENTOGENE to Participate in Upcoming Conferences in August\",\"datePublished\":\"2023-08-07T10:34:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/\"},\"wordCount\":787,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4ODM5NCM1NzQwMDE5IzIxMjU1NDg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/\",\"name\":\"CENTOGENE to Participate in Upcoming Conferences in August - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4ODM5NCM1NzQwMDE5IzIxMjU1NDg=\",\"datePublished\":\"2023-08-07T10:34:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4ODM5NCM1NzQwMDE5IzIxMjU1NDg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4ODM5NCM1NzQwMDE5IzIxMjU1NDg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-conferences-in-august\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE to Participate in Upcoming Conferences in August\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE to Participate in Upcoming Conferences in August - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/","og_locale":"en_US","og_type":"article","og_title":"CENTOGENE to Participate in Upcoming Conferences in August - Market Newsdesk","og_description":"CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Aug. 07, 2023 (GLOBE NEWSWIRE) &#8212; Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its conference schedule for August 2023. CENTOGENE representatives are attending events in Brazil and Switzerland, and will be available to discuss Pharma, CRO, and Diagnostic collaboration opportunities. The Company invites attendees to schedule one-on-one meetings in advance. Please see additional details below: XXXIV Brazilian Congress of Medical Genetics Dates:\u00a0August 13-16Location:\u00a0Frei Caneca Convention Center, S\u00e3o Paulo, BrazilFor information about the XXXIV Brazilian Congress of Medical Genetics and to arrange a one-on-one meeting, please refer to the event webpage (https:\/\/link.centogene.com\/47oVr9i). BioValley Basel \u2013 Annual EventDate:\u00a0August 29, 2023, 5:00 p.m. CESTLocation:\u00a0Claraspital &hellip; Continue reading \"CENTOGENE to Participate in Upcoming Conferences in August\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-07T10:34:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODM5NCM1NzQwMDE5IzIxMjU1NDg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CENTOGENE to Participate in Upcoming Conferences in August","datePublished":"2023-08-07T10:34:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/"},"wordCount":787,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODM5NCM1NzQwMDE5IzIxMjU1NDg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/","name":"CENTOGENE to Participate in Upcoming Conferences in August - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODM5NCM1NzQwMDE5IzIxMjU1NDg=","datePublished":"2023-08-07T10:34:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODM5NCM1NzQwMDE5IzIxMjU1NDg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODM5NCM1NzQwMDE5IzIxMjU1NDg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-conferences-in-august\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE to Participate in Upcoming Conferences in August"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/775771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=775771"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/775771\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=775771"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=775771"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=775771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}